Quidel Corporation
318 articles about Quidel Corporation
-
Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Emergency Use Authorization and CE Mark for Molecular Detection of COVID-19, Without Extraction Step
5/19/2020
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received Emergency Use Authorization (EUA) for the Lyra® Direct SARS-CoV-2 Assay from the Food and Drug Administration (FDA) to allow direct sample processing.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
-
Quidel Reports First Quarter 2020 Financial Results
5/6/2020
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced financial results for the first quarter ended March 31, 2020.
-
Quidel’s Lyra® Direct SARS-CoV-2 Assay Submitted for Emergency Use Authorization for Molecular Detection of COVID-19, Without Extraction Step
4/22/2020
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has applied for an Emergency Use Authorization (EUA) for the Lyra® Direct SARS-CoV-2 Assay from the Food and Drug Administration (FDA) to allow direct sample processing.
-
Quidel to Hold First Quarter 2020 Financial Results Conference Call on May 6th, 2020
4/21/2020
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2020 financial results after market close on Wednesday, May 6, 2020.
-
Quidel’s Lyra® SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19; Also Receives CE Mark, Health Canada Authorization
3/26/2020
Quidel Corporation announced that Quidel’s Lyra® SARS-CoV-2 Assay has received expanded Emergency Use Authorization claims from the Food and Drug Administration to allow testing with three additional thermocyclers: Applied Biosystems 7500 Standard, Roche LightCycler 480, and Qiagen Rotor-Gene Q.
-
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
-
Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay
3/18/2020
Quidel Corporation announced that Quidel has received Emergency Use Authorization from the U.S. Food and Drug Administration to market its Lyra® SARS-CoV-2 Assay, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or oropharyngeal swab specimens from patients suspected of COVID-19 by their healthcare provider.
-
Quidel Reports Fourth Quarter and Full Year 2019 Financial Results
2/12/2020
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and the year ended December 31, 2019.
-
Quidel to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on February 12th, 2020
1/28/2020
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fourth quarter and full year 2019 financial results after market close on Wednesday, February 12, 2020.
-
Quidel Announces Preliminary Revenue for Fourth Quarter 2019
1/9/2020
Expects revenues in the fourth quarter of 2019 to be in the range of $151 million to $152 million.
-
Quidel to Present at Upcoming Conferences
11/14/2019
31st Annual Piper Jaffray Healthcare Conference to be held at the Lotte New York Palace hotel in New York, New York on Wednesday, December 4, 2019 at 2:00 p.m. Eastern Time
-
Quidel Reports Third Quarter 2019 Financial Results
10/30/2019
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2019.
-
Quidel to Hold Third Quarter 2019 Financial Results Conference Call on October 30th, 2019
10/17/2019
Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions.
-
Quidel Reports Second Quarter 2019 Financial Results
8/8/2019
Financial results for the second quarter ended June 30, 2019.
-
Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019
7/26/2019
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report second quarter 2019 financial results after market close on Thursday, August 8, 2019.
-
Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel’s Triage® MeterPro Instrumented System
6/19/2019
Quidel Corporation announced that Quidel has received 510 clearance from the Unites States Food and Drug Administration to market the Quidel Triage® TOX Drug Screen, 94600, a fluorescence immunoassay for the qualitative determination of the presence of drug and/or metabolites in human urine of up to 9 drug assays.
-
Quidel Announces Private Exchange Transactions - June 4, 2019
6/4/2019
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 3.25% Convertible Senior Notes due 2020.
-
Quidel to Present at William Blair 39th Annual Growth Stock Conference
5/21/2019
Quidel Corporation announced that it will present at the William Blair 39th Annual Growth Stock Conference at the Loews Chicago hotel in Chicago, Illinois on Thursday, June 6, 2019.
-
Quidel Reports First Quarter 2019 Financial Results
5/8/2019
Announced today financial results for the first quarter ended March 31, 2019.